Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: A before/after clinical trial

Veterinary Microbiology

Volumn 146, Issue 3-4, 2010, Pages 309-313

  Hawkins, Catherine ^a   Harper, David ^a   Burch, David ^b   Änggård, Erik ^a   Soothill, James ^c  

^a Biocontrol Limited   (United Kingdom)

^b Octagon Services Ltd   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Bacteriophage; Dog; Otitis; Pseudomonas

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COUNT; BACTERIOPHAGE; BACTERIOPHAGE TYPING; DOG; FOLLOW UP; NONHUMAN; OTITIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; TREATMENT OUTCOME;

ANIMALS; BACTERIAL LOAD; DOG DISEASES; DOGS; EAR CANAL; OTITIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PSEUDOMONAS PHAGES; TREATMENT OUTCOME;

CANIS FAMILIARIS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 78650305211     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2010.05.014     Document Type: Article

References (23)

1. Adams M.H. Bacteriophages 1959, Interscience Publishers Inc., New York, pp. 447-448.
2. Barrow P., Lovell M., Berchieri A. Use of lytic bacteriophage for control of experimental Escherichia coli septicaemia and meningitis in chickens and calves. Clinical and Diagnostic Laboratory Immunology 1998, 5:294-298.
3. Brothers A.M., Gibbs P.S., Wooley R.E. Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro. Veterinary Therapeutics: Research in Applied Veterinary Medicine 2002, 3:493-500.
4. Cerveny K.E., De Paola A., Duckworth D.H., Gulig P.A. Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice. Infection and Immunity 2002, 70:6251-6262.
5. Dixon B. New dawn for phage therapy. The Lancet Infectious Diseases 2004, 4:186.
6. Dubos R.J., Straus J.H., Pierce C. The multiplication of bacteriophage in vivo and its protective effect against an experimental infection with Shigella dysenteriae. Journal of Experimental Medicine 1943, 78:161-168.
7. Hare R., Fry R.M. Preliminary observations of an infection of dogs by beta haemolytic Streptococci. Veterinary Record 1938, 50:213-218.
8. Huff W.E., Huff G.R., Rath N.C., Balog J.M., Donoghue A.M. Therapeutic efficacy of bacteriophage and Baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers. Poultry Science 2004, 83:1944-1947.
9. Martin-Barrasa J.L., Lupiola-Gomez P., Gonzalez-Lama Z., Tejedor-Junco M.T. Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa. Journal of Veterinary Medicine B: Infectious Diseases and Veterinary Public Health 2000, 47:191-196.
10. Matsuzaki S., Yasuda M., Nishikawa H., Kuroda M., Ujihara T., Shuin T., Shen Y., Jin Z., Fujimoto S., Nasimuzzaman M.D., Wakiguchi H., Sugihara S., Sugiura T., Koda S., Muraoka A., Imai S. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. Journal of Infectious Diseases 2003, 187:613-624.
11. Morris D.O. Medical therapy of otitis externa and otitis media. Veterinary Clinics of North America: Small Animal Practice 2004, 34:541-555.
12. Sivera-Marza J.A., Soothill J.S., Boydell P., Collyns T.A. Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients. Burns 2006, 32:644-646.
13. Smith H.W., Huggins R.B. Successful treatment of experimental E. coli infections in mice using phage: its general superiority over antibiotics. Journal of General Microbiology 1982, 128:307-318.
14. Smith H.W., Huggins R.B., Shaw K.M. Effectiveness of phages in treating experimental E.coli diarrhoea in calves, piglets and lambs. Journal of General Microbiology 1983, 129:2659-2675.
15. Smith H.W., Huggins R.B., Shaw K.M. The control of experimental E. coli diarrhoea in calves by means of bacteriophage. Journal of General Microbiology 1987, 133:1111-1126.
16. Soothill J.S., Hawkins C., Änggård E., Harper D. Therapeutic use of bacteriophages. Lancet Infectious Diseases 2004, 4:544-545.
17. Soothill J.S. Treatment of experimental infections of mice with bacteriophages. Journal of Medical Microbiology 1992, 37:258-261.
18. Soothill, J.S., 1993. Use of bacteriophage in the treatment of infections. MD thesis. University of London.
19. Soothill J.S. Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. Burns 1994, 20:209-211.
20. Teresa-Tejedor M., Martin J.L., Navia M., Freixes J., Vila J. Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from canine infections. Veterinary Microbiology 2003, 30:295-301.
21. Wills Q.F., Kerrigan C., Soothill J.S. Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrobial Agents and Chemotherapy 2005, 49:1220-1221.
22. Wolfensohn S., Lloyd M. Handbook of Laboratory Animals 2003, Backwell Publishing, Oxford, UK. 3rd edition.
23. Wright A., Hawkins C.H., Änggård E.E., Harper D.R. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa. Clinical Otolaryngology 2009, 34:349-357.